---

Background and Objective: Colorectal cancer is one of the most common cancers and considered to be leading causes of cancer death in the world. One of the problems with this type of cancer is its inability to be detected in early stage. The aim of present study was to evaluate the correlation between the serum levels of Fucosyltransferase-4 and galactin-3 in patients with early-stage of colorectal cancer.
Methods: This case-control study was done on 40 patients with early stages of colorectal cancer and 40 healthy subjects. ELISA method was used to measure the serum levels of Fucosyltransferase-4 and galactin-3. To examine the correlation between the variables, correlation test and Pearson correlation coefficient index were used.
Results: Fucosyltransferase-4 and galactin-3 levels were higher in patients with early-stage of colorectal cancer compared to healthy subjects. This difference was not significant. In patients with colorectal cancer, there was a significant relationship between the level of Fucosyltransferase-4 and galactin-3 (r=0.71, P=0.01).
Conclusion: Simultaneous measurement of Fucosyltransferase-4 and galactin-3 is useful in identifying early-stage of colorectal cancer as a non-invasive laboratory method.

---

Background and Objective: Micro-ribonucleic acids (microRNAs) have introduced a new field in the molecular diagnosis of cancer. However, the role of circulating microRNAs in the plasma/serum of colorectal cancer patients is still unclear. This study was conducted to determine the expression of let-7d microRNA in patients with colorectal cancer.
Methods: This case-control study was conducted on 40 patients with colorectal cancer and 40 healthy people. In this study, 7 mL blood samples were collected from patients with colorectal cancer (both before and after tumor resection) and healthy individuals (only once). The serum samples were isolated and stored at - 80°C until molecular analysis. MicroRNAs were extracted from serum samples, and cDNA was synthesized. Let-7d expression was examined using the RT-qPCR method. Data were analyzed using GraphPad Prism v. 9 software. The receiver operating characteristic (ROC) curve analysis, sensitivity, and specificity were also calculated for the let-7d microRNA data to introduce a diagnostic biomarker between the preoperative patient group and the control group.
Results: In the preoperative samples of the patients, the expression of let-7d microRNA was significantly lower than that of the control group (P˂0.05). The expression of let-7d microRNA significantly increased after tumor resection compared to before. The ROC analysis for let-7d microRNA in the preoperative patient group with the control group showed that the sensitivity was 33.3%, specificity was 92.3%, and the area under the curve (AUC) was 0.622.
Conclusion: Let-7d microRNA could potentially serve as a new noninvasive diagnostic biomarker for the early detection of colorectal cancer. However, further studies are required on this subject.

---

Background and Objective: Colorectal cancer is the third most common cancer in men and the second most common in women. The use of parasites or parasite antigens is one of the newest therapeutic approaches for cancer, although it has not yet been used or approved in human trials. This study aimed to determine the cytotoxic effects of purified carbohydrates from the hyaline layer, fluid, and protoscolices of hydatid cysts on the human colorectal cancer cell line (LS174T).
Methods: This descriptive-analytical study was conducted on two sheep and two cow livers infected with hydatid cysts, and the human colorectal adenocarcinoma cell line (LS174T) purchased from the Pasteur Institute of Iran at the Faculty of Veterinary Medicine, Shahid Chamran University of Ahvaz, Iran during 2022. Cyst fluid, protoscolices, and the hyaline layer were isolated from the hydatid cyst-infected livers, and glycoproteins and glycolipids from different parts of the cyst were extracted using the chloroform-methanol method. Carbohydrates were purified using the beta-elimination method and their presence was confirmed using the phenol-sulfuric acid method. The cytotoxicity of purified carbohydrates on the LS174T cell line was evaluated using the methyl tetrazolium (MTT) assay for 24 hours.
Results: Concentrations of 0.5 and 0.25 of purified carbohydrates from glycoproteins and glycolipids of hydatid cysts significantly inhibited the growth of LS174T cells (P<0.05). Initial cytotoxicity evaluation showed that purified carbohydrates from glycoproteins of sheep cyst fluid (38.60±1.33%), glycoproteins of cow cyst hyaline layer (36.61±1.76%), glycolipids of cow cyst hyaline layer (38.94±2.99%), glycoproteins of cow cyst protoscolices (40.27±3.66%), and glycolipids of sheep cyst protoscolices (37.94±1.99%) had significantly more pronounced inhibitory effects (P<0.05). Subsequent screening with the MTT assay revealed that purified carbohydrates from glycoproteins isolated from sheep hydatid cyst fluid (52.35±10.24%), glycolipids isolated from cow hydatid cyst hyaline layer (53.40±7.88%), and glycolipids isolated from sheep hydatid cyst protoscolices (53.05±5.06%) had significantly more pronounced inhibitory effects on the growth of LS174T cancer cells (P<0.05).
Conclusion: Carbohydrates isolated from glycoproteins and glycolipids of the hyaline layer, fluid, and protoscolices of hydatid cysts have significant anticancer effects on the LS174T colorectal cancer cell line.